![]() |
市場調查報告書
商品編碼
1513765
全球氣道/肺支架市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測Global Airway/Lung Stent Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球氣道/肺支架市場需求預計將從2023年的11797萬美元達到2032年近22037萬美元的市場規模,2024-2032年研究期間複合年成長率為7.19%。
氣道/肺支架是一種醫療器械,用於使患有導致氣道阻塞的患者保持氣道暢通,例如腫瘤、狹窄或慢性支氣管炎。這些支架由矽膠或金屬等材料製成,插入氣管或支氣管以保持通暢並改善呼吸。氣道支架可以是臨時的,也可以是永久性的,有各種形狀和尺寸,以適應呼吸道的不同部位。通常使用支氣管鏡技術放置它們。透過為氣道提供結構支撐,這些支架在緩解阻塞性氣道疾病患者的症狀和提高生活品質方面發揮著至關重要的作用。
慢性阻塞性肺病、肺癌和氣管狹窄等呼吸系統疾病的盛行率不斷增加,正在推動氣道/肺支架市場的成長。支架設計的技術進步,例如開發更耐用和靈活的材料,正在提高其有效性和安全性,並推動其採用。人們越來越認知到微創手術的好處以及保持氣道通暢對於改善阻塞性氣道疾病患者的生活品質的重要性,這也促進了市場的成長。擴大醫療基礎設施和服務提供了新的市場機會,特別是在新興經濟體。旨在改善呼吸系統疾病管理的政府措施和醫療保健計劃正在進一步支持市場。
人口老化更容易受到呼吸系統疾病的影響,是促進市場成長的另一個重要因素。此外,對以患者為中心的護理的日益關注和個性化治療計劃的開發推動了對氣道/肺支架的需求。正在進行的研發活動專注於增強這些支架的設計和功能,預計將透過提供滿足醫療保健提供者和患者不斷變化的需求的創新解決方案來推動市場。然而,氣道/肺支架的高成本以及支架移位和感染等併發症的可能性可能會挑戰未來幾年的市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球氣道/肺支架市場的各個細分市場進行了包容性評估。氣道/肺支架產業的成長和趨勢為本研究提供了整體方法。
氣道/肺支架市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的氣道/肺支架市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。氣道/肺支架市場的主要參與者包括波士頓科學公司(美國)、Taewoong Medical Co. Ltd.(韓國)、Micro-Tech(南京)有限公司(中國)、Novatech SA(法國)、Boston Medical Products Inc .(美國)、E. Benson Hood Laboratories Inc.(美國)、Merit Medical Systems Inc.(美國)、Cook Group(美國)、EFER Endoscopy(法國)、ENDO-Flex GmbH(德國)、Standard Sci 。 Tech Inc.(韓國)、Stening SRL(阿根廷)。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Airway/Lung Stent Market is presumed to reach the market size of nearly USD 220.37 Million by 2032 from USD 117.97 Million in 2023 with a CAGR of 7.19% under the study period 2024-2032.
An airway/lung stent is a medical device to keep the airways open in patients with conditions that cause airway obstruction, such as tumors, strictures, or chronic bronchitis. Made from materials like silicone or metal, these stents are inserted into the trachea or bronchi to maintain patency and improve breathing. Airway stents can be temporary or permanent and come in various shapes and sizes to fit different parts of the respiratory tract. They are typically placed using bronchoscopic techniques. By providing structural support to the airway, these stents play a crucial role in alleviating symptoms and improving the quality of life for patients with obstructive airway diseases.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease, lung cancer, and tracheal stenosis, is driving the growth of the airway/lung stent market. Technological advancements in stent design, such as the development of more durable and flexible materials, are enhancing their effectiveness and safety, driving their adoption. The increasing awareness of the benefits of minimally invasive procedures and the importance of maintaining airway patency in improving the quality of life for patients with obstructive airway diseases is also boosting market growth. Expanding healthcare infrastructure and services provides new market opportunities, particularly in emerging economies. Government initiatives and healthcare programs aimed at improving the management of respiratory diseases are further supporting the market.
The aging population, more susceptible to respiratory conditions, is another significant factor contributing to the market's growth. Moreover, the increasing focus on patient-centered care and the development of personalized treatment plans drive the demand for airway/lung stents. The ongoing research and development activities focused on enhancing the design and functionality of these stents are expected to drive the market by offering innovative solutions that cater to the shifting needs of healthcare providers and patients. However, the high cost of airway/lung stents and the potential for complications such as stent migration and infection may challenge market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Airway/Lung Stent. The growth and trends of Airway/Lung Stent industry provide a holistic approach to this study.
This section of the Airway/Lung Stent market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Airway/Lung Stent market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Airway/Lung Stent market include Boston Scientific Corporation (US), Taewoong Medical Co. Ltd. (South Korea), Micro-Tech (Nanjing) Co. Ltd. (China), Novatech SA (France), Boston Medical Products Inc. (US), E. Benson Hood Laboratories Inc. (US), Merit Medical Systems Inc. (US), Cook Group (US), EFER Endoscopy (France), ENDO-Flex GmbH (Germany), Standard Sci. Tech Inc. (South Korea), Stening SRL (Argentina). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.